| 产品详情 |
| Edit |   |
|---|
| Product Name | TAK-700 |
|---|
| Description | Purity 98%. Orteronel (TAK-700) was selected as a candidate for clinical evaluation. orteronel (TAK-700) is currently in phase III clinical trials for the treatment of castration-resistant prostate cancer. |
|---|
| Size | 2 mg, 5 mg, 1ml/10mM (In DMSO), 10 mg, 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | CAS: 566939-85-3 |
|---|
| Catalog # | MBS578626 |
|---|
| Price | |
|---|
| Order / More Info | TAK-700 from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|